Addus HomeCare Corp.

Day range

$120.75 – $123.01

Open

$122.35

Prev close

$122.67

Volume

221.41K

Market cap

$2.29B

Shares out

18.67M

P/E

21.75

P/S

1.55

P/B

2.00

P/FCF

14.80

ROE

9.2%

ROA

7.2%

Debt/Equity

0.05

Div yield

0.00%

As of Oct 22, 2026

• Deal agreementsSep 14, 2026

  Pursuant to the Purchase Agreement, Addus HealthCare has agreed to consummate the Transaction for a purchase price of $275,000,000 in cash, subject to typical adjustments for working capital and other customary items.

• Executive leadershipAug 13, 2026

  On August 7, 2026, Heather Dixon, President and Chief Operating Officer of Addus HomeCare Corporation (the "Company") left the Company. The Company thanks Ms. Dixon for her service and contributions and wishes her all the best in her future endeavors.

• Shareholder meetingsJun 10, 2026

  At the 2026 annual meeting of the stockholders (the "Annual Meeting") of Addus HomeCare Corporation (the "Company") held on June 10, 2026, a total of 17,557,334 shares of the Company's common stock, out of a total of 18,664,776 shares of common stock outstanding and entitled to vote, were present in person or represented by proxies. The Company's stockholders (i) elected Michael Earley and Veronica Hill-Milbourne, to serve as Class II directors for terms expiring at the 2029 annual meeting of the Company's stockholders; (ii) ratified the appointment of PricewaterhouseCoopers LLP, an independent registered public accounting firm, as the Company's independent auditor for fiscal year 2026; and (iii) approved on an advisory, non-binding basis, the Company's compensation of its named executive officers.

• Executive leadershipAug 7, 2025

  On August 4, 2025, Addus HealthCare, Inc. entered into an Employment and Non-Competition Agreement with Heather Dixon, pursuant to which Ms. Dixon, age 52, will join the Company as President and Chief Operating Officer, commencing on September 15, 2025. Ms. Dixon most recently served as Chief Financial Officer of Acadia Healthcare, the largest stand-alone behavioral healthcare company in the United States.

• Shareholder meetingsJun 23, 2025

  At the 2025 annual meeting of the stockholders (the "Annual Meeting") of Addus HomeCare Corporation (the "Company") held on June 18, 2025, a total of 17,431,919 shares of the Company's common stock, out of a total of 18,399,139 shares of common stock outstanding and entitled to vote, were present in person or represented by proxies. The Company's stockholders (i) elected Esteban López, M.D., Jean Rush and Susan T. Weaver, M.D., FACP, to serve as Class I directors for terms expiring at the 2028 annual meeting of the Company's stockholders; (ii) ratified the appointment of PricewaterhouseCoopers LLP, an independent registered public accounting firm, as the Company's independent auditor for fiscal year 2025; (iii) approved on an advisory, non-binding basis, the Company's compensation of its named executive officers as set forth in the Proxy Statement; and (iv) approved on an advisory, non-binding basis, the frequency of holding a non-binding advisory vote on named executive officer compensation as set forth in the Proxy Statement every year.

Days to cover

3.9

Short interest

922.89K

Avg volume

235.98K

As of Sep 30, 2026 · reported to FINRA twice monthly.

• Quest Diagnostics (DGX) Q3 Earnings and Revenues Beat Estimates
  positiveZacks Investment Research· Oct 22, 2026
• BTSG Deploys AI Across Operations: Will It Improve Margins?
  positiveZacks Investment Research· Sep 30, 2026
• Can BTSG Outgrow the $20B Acute Infusion Market on Volume Growth?
  positiveZacks Investment Research· Sep 4, 2026
• 3 Healthcare Stocks Providing Relief for the Sandwich Generation
  positiveInvesting.com· Apr 10, 2026
• United Kingdom Healthcare Market Report 2024: The Role of Private Payers and Independent Sector Providers, Alongside the Public Sector, in the Funding and Delivery of UK Health and Care Services
  neutralGlobeNewswire Inc.· Aug 7, 2024